VolitionRx Acquires Octamer GmbH

Represented VolitionRx in its acquisition of Octamer GmbH by its subsidiary Belgian Volition SPRL for approximately $725,000. VolitionRx is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases.